1. Home
  2. East Africa
  3. Uganda
  • News

Pfizer helps carry AIDS treatment burden

Uganda's HIV testing boom has resulted in more patients than the country can handle, the head of Pfizer, the world's largest drug company, said on Friday. Pfizer CEO Hank McKinnell told Reuters, "Four or five years ago, the objective was to ... get people tested and then get them into counselling and care. We have moved past that. Testing is now more routine in Uganda, but that has created a new problem ... We now have more patients than we can possibly deal with." At the launch of a new anti-AIDS clinic in the western Ugandan town of Mbarara, funded in part by Pfizer, McKinnell said he hoped the centre would help alleviate the patient load by providing treatment to at least 1,000 patients. Uganda was previously regarded as the epicentre of the AIDS pandemic in Africa, but a government education campaign that placed great emphasis on testing has cut infection rates from 30 percent to about 6 percent.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join